News und Analysen
EQS-News: Carl Zeiss Meditec achieves further strong revenue growth after nine months of fiscal year 2022/23 with continued high strategic investments
Why Coherus BioSciences Stock Popped Today
Shares of Coherus BioSciences (NASDAQ: CHRS) soared 17.7% on Thursday, according to data provided by S&P Global Market Intelligence, after the biotech company announced better-than-expected
EQS-News: Invitation to MorphoSys’ Second Quarter and First Half 2023 Financial Results Conference Call on August 10, 2023
Cigna Group (CI) Q2 2023 Earnings Call Transcript
Image source: The Motley Fool.
Cigna Group (NYSE: CI)Q2 2023 Earnings CallAug 03, 2023, 8:30 a.m. ET
Operator
Source Fool.com
EQS-News: SARTORIUS AG: Florian Funck appointed CFO of Sartorius
Humana Foundation Announces 2023 Scholarship Awards
The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM) for the past 41 years, today announced 81 winners of college scholarships awarded through the Humana Foundation Scholarship
Got $5,000? These 2 Stocks Could Be Bargain Buys for 2023 and Beyond
The stock market is roaring back in 2023 following a downturn. However, the year hasn't been kind to every company. For instance, drugmakers AbbVie (NYSE: ABBV) and Axsome Therapeutics (NASDAQ:
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
3 Dividend Stocks That Hiked Payouts by 60% in Just 5 Years
Want a good dividend stock to own? Don't focus just on the yield itself. When it comes to long-term dividend income, it's important to consider businesses that are growing and that have the
1 Green Flag and 1 Red Flag for Tilray Stock
Canadian cannabis company Tilray Brands (NASDAQ: TLRY) has been on the right track ever since it merged with rival Aphria in 2021. From an operational standpoint, it had been consistently
3 High-Yielding Dividend Stocks to Buy and Hold for Decades
According to a recent Ipsos poll, one in five Americans don't expect to retire, and that's largely because they don't feel they can afford to do so. One way for Americans to improve their financial
This Is Arguably the Single Best Stock to Buy Right Now
What's the single best stock to buy right now? Ask five different investors and you'll probably get five different answers.
The problem, of course, is that defining what makes a given candidate the
AT&T's Dividend Just Got a Bit Safer
AT&T (NYSE: T) pays a high dividend that yields 7.6%. At that level of payout, investors owning a little more than $13,100 in stock would collect $1,000 in annual dividend income. But when it comes
Sarepta Therapeutics (SRPT) Q2 2023 Earnings Call Transcript
Image source: The Motley Fool.
Sarepta Therapeutics (NASDAQ: SRPT)Q2 2023 Earnings CallAug 02, 2023, 4:30 p.m. ET
Operator
Source Fool.com
Why Shares of Nevro Are Down Wednesday
Shares of Nevro (NYSE: NVRO) were down more than 19% as of 3:30 p.m. ET on Wednesday after the company announced second-quarter earnings. The healthcare stock is down more than 49% so far this year
Karyopharm Therapeutics (KPTI) Q2 2023 Earnings Call Transcript
Image source: The Motley Fool.
Karyopharm Therapeutics (NASDAQ: KPTI)Q2 2023 Earnings CallAug 02, 2023, 8:00 a.m. ET
Operator
Source Fool.com
Why Shares of Blueprint Medicines Are Falling Wednesday
Shares of Blueprint Medicines (NASDAQ: BPMC) were down more than 12% as of 12:45 p.m. on Wednesday after the healthcare company announced second-quarter earnings. The stock is still up more than 27%
This Deep Value Stock Is a Strong Buy
Value investing can be a powerful strategy. Buying businesses for less than they are worth can limit your risk of significant capital losses, and it can increase your chances of future upside.
The
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Exelixis (EXEL) Q2 2023 Earnings Call Transcript
Image source: The Motley Fool.
Exelixis (NASDAQ: EXEL)Q2 2023 Earnings CallAug 01, 2023, 5:00 p.m. ET
Operator
Source Fool.com
Pfizer (PFE) Q2 2023 Earnings Call Transcript
Image source: The Motley Fool.
Pfizer (NYSE: PFE)Q2 2023 Earnings CallAug 01, 2023, 10:00 a.m. ET
Operator
Source Fool.com
Vertex Pharmaceuticals (VRTX) Q2 2023 Earnings Call Transcript
Image source: The Motley Fool.
Vertex Pharmaceuticals (NASDAQ: VRTX)Q2 2023 Earnings CallAug 01, 2023, 4:30 p.m. ET
Operator
Source Fool.com
Merck (MRK) Q2 2023 Earnings Call Transcript
Image source: The Motley Fool.
Merck (NYSE: MRK)Q2 2023 Earnings CallAug 01, 2023, 8:00 a.m. ET
Operator
Source Fool.com
2 Cheap Tech Stocks to Buy Hand Over Fist
The stock market has surged this year, and tech stocks have done particularly well. While the S&P 500 is up about 19% year to date, the tech-heavy Nasdaq Composite has soared roughly 37 %.
The
Is AT&T's 7.6% Dividend Safe?
When analyzing a dividend stock, pretty much every piece of advice will tell you to avoid stocks paying higher than a 5% or 6% dividend. This is because the market has dropped the stock's share